Aktis Oncology
(Incorporated in Delaware) We are a clinical oncology company developing radiopharmaceuticals to treat solid tumors. Our lead drug candidates are: -Ac-AKY-1189 to treat cancers that express Nectin-4 – We are now enrolling 150 patients in a Phase 1B trials with preliminary results expected in the first quarter of 2027, and –Ac-AKY-2519 to treat tumors that […]
December 20, 2025 Read More